Back to search
Intravitreal Injection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Intravitreal Injection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Intravitreal Injection trials you may qualify forThe purpose of this study is to evaluate the safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of multiple doses of RO7823653 in participan…
This is a sequential Phase 1/2, two-part, multicenter study on safety, tolerability, and efficacy of one-time intravitreal SAR446597 for the treatment of partic…
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
A Phase 1/2, open-label, non-randomized, dose-escalation study, where a minimum of 9 and a maximum of 18 eligible patients with Stargardt Disease will be enroll…
This study evaluates the safety of a single injection of jCell (famzeretcel) comprising 6.0 million (6.0M) retinal progenitor cells over a six-month study perio…
In just a few years, intravitreal injections have become a standard method of administration for certain retinal deseases (age-related macular degeneration \[AM…
The main purpose of this study is to assess the ocular and systemic safety and tolerability of RO7669330 in participants with GA secondary to AMD in at least on…
The purpose of this research study is to test whether a personalised care approach improves adherence compared to standard care. Many patients with macular dise…